{"name":"Marks, John, M.D.","slug":"marks-john-m-d","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNcGx2MnlsR0VPdlZJZWJKQjMzUXY3SEx1dmtHcVpmWVV0UWpLc3pGRzNlMExDOUwtMGhnbDVzVHBPQlp2VExEU1lUazQ3VVZXcmx3a1lMWVFfNHlrZU8zYUI4QnZJaUM1MTFqS2lpQjhWSkthZjMtanhFYy1mQWtNVU1JYXlJY1l3R2xkME92ZTlETTFNQWlYRndSMUMzV3VKMHlCVVFVTHNUVEU3VGZEcVRhazd0Yzg?oc=5","date":"2026-02-27","type":"deal","source":"fiercepharma.com","summary":"Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up - fiercepharma.com","headline":"Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFAyMVB0R0ZUNDhLeFdiX2lSQ2QwR2l0ek5NSGpjOEY0eFRjR0xoZHFVUWN1NVUzWHE5WDlEUVJ2M01BYkpqNjRhOTc3eGtTMXVzNmNVS2p4RkpBX1JDeGM2aG02bw?oc=5","date":"2026-01-14","type":"pipeline","source":"Pharmacy Business","summary":"Exciting News: AAH Pharmaceutical Announces Shared MD Role! - Pharmacy Business","headline":"Exciting News: AAH Pharmaceutical Announces Shared MD Role!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPX3lBZ3VRbDhwYlhuM2lvaEhlWE1yQ3pyZ3Z4bXJvcjZ4ckRQU2JSZjViby1pQ1l5d2puVDZZVzFKWEpZTGZkN0dNUVN0d0x3YWhxR1ZRc3dBeUNmUWZKNlNRZWdHT3NRd3oybDZwOUQtVzJPN0w4MXZ2OTM0TC1McF9jZ2IxWHkzUmdRcjFMMXFOY214d1RHbUt5dHBzNUN6QUo0LXVQMmkxTmNWQmUzOUNnTQ?oc=5","date":"2025-12-22","type":"pipeline","source":"Pharmaceutical Commerce","summary":"Samsung Biologics Enters US Manufacturing Market with $280M GSK Site Acquisition - Pharmaceutical Commerce","headline":"Samsung Biologics Enters US Manufacturing Market with $280M GSK Site Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNWXNCTmQtOTk3MFZ6LXNkb1hfeUdaeHdyYjkzYWtOZUZtZXEzZkxTR2hOUDRJUWk3VWI2bnNJZE1sWVdteGFzWVRfV0dpQm5YbFVhRmVVa0dLSWExaHJvM2VMbEpMT3g5NW1XLWhWN3FCLU81Vlk1UmZFS2E0bFVBR3lyQlp3NVZJRzl0MDdYcXpCYUwwQnlpOWVaSGNPall2bVJrdVhWWUVkZDRMdmxJOWROSHM?oc=5","date":"2025-12-02","type":"regulatory","source":"Ophthalmology Times","summary":"FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05% - Ophthalmology Times","headline":"FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxOaVFiYTQ1N3pQTzRBRDgwMXpJdmR2ZmEyYm1XMFR0TU1tYzlTSWRVazdOcHVwR0JlRHlyMXIzMkpFTENXOURzSnByTGhteG94NGhIZDdtUjVvR0U1V1lKSGFocU9IMl9mODNSNS1EOFI5aWtadjNBaGhES2JKX2sxLTN1OHAzM2FnYTFsQ0NvWkctaS1VcUxBTFFFYnd5TldkdzdEcDBBdGZlMHplWnZJM0xUUnU4YkNzcUxoMDVEZXlteTVBVHMza2hoNFhLb2dHZ1NHUGdPOXdDY2Z3aWdGcnZ2VE50N0w0NV8tNTBzelBSMUtaZmVWOEhZUERVVUhRUGlNeVdMSnlSQjJnQ09GRnNjdw?oc=5","date":"2025-11-06","type":"pipeline","source":"The University of Maryland, Baltimore","summary":"2025 Archive - The University of Maryland, Baltimore","headline":"2025 Archive - The University of Maryland, Baltimore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNFVBb3lfZzZNa0toR21ONGtMeGdqU216blZsbl9qUzI1MTN4Y3pxSzFSSlBpSllKX1cyZ2hVajhEUnlWcmZsczFOMEpoZ0JMcGVCczhPNmFwTWhyTkc5MzdSSzMzMktETXRDTkF6YXNWUXlIZTUxdWh6MHhCdURKUTQ1ZGNRTnVBaDBrcEJWM3dsNkZJRDFhLVNwZDVZRWIweDFBcV9OeThkcUJhdEszMHc5eTByZ2EyWUlTVVV6eUs?oc=5","date":"2025-09-10","type":"regulatory","source":"fiercepharma.com","summary":"J&J's 'practice-changing' bladder cancer therapy Inlexzo lands FDA nod - fiercepharma.com","headline":"J&J's 'practice-changing' bladder cancer therapy Inlexzo lands FDA nod","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFAxMTQ3a0JEZDdwY1hRTk5QWUJDYm0weWlEUEtUZjdQVVotSjAtRUxsQW4xelNSZlRYbm8xU2V1SHBrbUFiWEJxMTh2MF81cWhqbURuZEwzRU5kc3dVRnVQYm5RQlZpRWpYRnNrT1U3QXgwQkkxaGU3YjlENGN2LVE?oc=5","date":"2025-04-02","type":"regulatory","source":"Pharma Voice","summary":"Is the FDA ‘finished’? Leadership drain hits agency hard. - Pharma Voice","headline":"Is the FDA ‘finished’? Leadership drain hits agency hard.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQUUswTTl0azNJcGxnc2w0N1Z3OWk1Ul9HYU9ZQWV3bmF6amkyY3F4bVI1aWk3VlRCczZzZnFhTU0ydW5mUVNZYWM4S3lOdER4SUZXSDQ5UnVvd3FHYXI5RjlQRk1hNUZlcms0UVh1akR4Z2ZpUWhVcFlaaUNUR3dtUHg2UDBkVlJjT0JmSVZUUFhTWWtjOGFZMS1LWVdFZw?oc=5","date":"2025-03-29","type":"regulatory","source":"statnews.com","summary":"Ouster of FDA’s Peter Marks alarms a biopharma industry that saw him as an ally - statnews.com","headline":"Ouster of FDA’s Peter Marks alarms a biopharma industry that saw him as an ally","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNNmRPWmEzc2lRZ2Y4MFNjbFotZkNCMHdwVWtGbzg5bDZGNW5JcXI4dUk5MTlxRDBDS05NazdQSk9IdGFOQUZlanFsS01vaHBsckNzRGpZUHNMa0ZoSEhjYXVFRWc1ZWYwWFBjTm13Ml9GR1U5UVhMNGtYcnFpUEhkNnhiZG5hQjBlSHFOQzlYN3ZxVmRDZk92VTJSQVFDMVhqSkQxZGFseDNfdmFDTUs3QlN4Y1h6cENFaFNtSDJB?oc=5","date":"2024-06-07","type":"pipeline","source":"Healio","summary":"Mark Cuban’s Cost Plus Drug Company ‘flying under the radar’ after 2 years - Healio","headline":"Mark Cuban’s Cost Plus Drug Company ‘flying under the radar’ after 2 years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPVHhSM2k4MWdiVXcxVWpOUFNnRzgydXhSNjBmTy10Qld6WWQ0M3FSaWtkNGpVdmxRcG14bFR5VXg0NlJ0QlFiUjV2NFdSLUhhczhfWEU2ZV9GaXNjaThWb0ExTWVITDRVUk01bTJNbUpPRGE3YWt1ZU1YUUVvX1JVUWh6eUt0OFkxMmhqa2kzb2tkUVNDSlZwQTl3UnhUVm9ILXJ1TXlMM3N4Uk9lOHppOA?oc=5","date":"2024-04-11","type":"pipeline","source":"today.ucsd.edu","summary":"UC San Diego Secures Several Top Spots in Latest National Rankings for NIH Funding - today.ucsd.edu","headline":"UC San Diego Secures Several Top Spots in Latest National Rankings for NIH Funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQOGtZbG00N1Y4cGVCcXR6NEpFY0VqU0h4ZGpRQ3FadGpXOFdSeXZ1UzYtNXF2ZlpGd1BMaGRWNFpoM0lxRWtlS0xEb2szcDdEa25FNTVNNDlNRTlzREJJcjlPeEI3dGl2TXY1THBpV3I5SlFWeU9vdGVQYjM0T3lmMXNMcE45QXlDSXc2WjBUeTJUbjhmdnRJS1huVTBrdlBpX2hFbHVoQ2szX0RpNklvazJ6SQ?oc=5","date":"2024-01-19","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Hardy replaces BioMarin’s commercial chief in first big move as CEO - Fierce Biotech","headline":"Chutes & Ladders—Hardy replaces BioMarin’s commercial chief in first big move as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1OMFZGN2ZQYkJtTEtHekUwUlRVRzR5TVJEWlh4U081S0c5TFRVbGw1SDgzQ09fM1JNRThEcWo3dmdZSlVyLV9oXzdDOVFLMG9FZTZ0UkpVMzBTTmpUVEU4eQ?oc=5","date":"2019-02-07","type":"trial","source":"NEJM","summary":"Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors - NEJM","headline":"Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}